サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1672378

ジェネリック医薬品の世界市場レポート 2025年

Generic Pharmaceuticals Global Market Report 2025

出版日
ページ情報
英文 250 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ジェネリック医薬品の世界市場レポート 2025年
出版日: 2025年03月03日
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ジェネリック医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.9%で、6,664億8,000万米ドルに成長します。予測期間の成長は、慢性疾患の罹患率の増加、規制当局の支援の高まり、創薬の新手法、ドラッグデリバリーやモニタリングの新手法、医療支出の増加、高齢者の増加、主要な医薬品特許に起因すると考えられます。予測期間における主要動向としては、3Dプリンティングの利用増加、人工知能（AI）の採用、医薬品開発におけるバイオマーカーの利用、イノベーションを推進するための共同研究、併用薬剤療法、既存のてんかん治療の改良、呼吸器系治療のジェネリック医薬品の増加などが挙げられます。

慢性疾患の増加は、ジェネリック医薬品市場の重要な促進要因として際立っています。慢性疾患と診断される人の増加に伴い、医薬品に対する需要が高まっています。ブランド医薬品には高価格のものが多いが、ジェネリック医薬品は同じ化学成分で安価です。ジェネリック医薬品は手頃な価格で同等の効果が得られるため、特に慢性疾患に伴う長期の治療では、患者にとって好ましい選択肢となっています。例えば、世界保健機関（WHO）は、今後10年間で慢性疾患による死亡者数が17％増加すると予測しています。

ジェネリック医薬品市場の成長は、ジェネリック医薬品による費用対効果の高い治療が利用可能になることで促進されると予想されます。費用対効果の高い治療とは、妥当なコストで大きな健康上の利益をもたらす選択肢を指します。ジェネリック医薬品は、患者により手頃な治療選択肢を提供し、その結果、ブランド医薬品と比較して医療システムに大幅な節約をもたらします。例えば、2024年3月、米国の主要諮問機関である計画・評価担当次官補（ASPE）のデータによると、2022年にはメディケアパートD加入者の82％を占める4,330万人が11億件のジェネリック医薬品の配合を受けた。その結果、患者の自己負担額は57億米ドル、薬剤費総額は329億米ドルとなります。その結果、ジェネリック医薬品の費用対効果は、ジェネリック医薬品市場の成長の大きな原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のジェネリック医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界のジェネリック医薬品市場：成長率分析
  • 世界のジェネリック医薬品市場の実績：規模と成長、2019～2024年
  • 世界のジェネリック医薬品市場の予測：規模と成長、2024～2029年、2034年
  • 世界のジェネリック医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のジェネリック医薬品市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • バイオシミラー
  • ジェネリック
  • 世界のジェネリック医薬品市場：ドラッグデリバリー別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口
  • 感染可能
  • 経皮/局所
  • 世界のジェネリック医薬品市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • CNS
  • 心血管
  • 皮膚科
  • 泌尿生殖器/ハーモナル
  • 呼吸器
  • リウマチ学
  • 糖尿病
  • 腫瘍学
  • 吸入器
  • 世界のジェネリック医薬品市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界のジェネリック医薬品市場、バイオシミラーのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • モノクローナル抗体
  • 組み換えタンパク質
  • その他の生物製剤
  • 世界のジェネリック医薬品市場、ジェネリック医薬品のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • ブランドジェネリック
  • ジェネリック小分子
  • ジェネリック徐放性製剤
  • 市販のジェネリック医薬品

第7章 地域別・国別分析

  • 世界のジェネリック医薬品市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界のジェネリック医薬品市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ジェネリック医薬品市場：競合情勢
  • ジェネリック医薬品市場：企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • Fresenius Kabi
    • Aurobindo Pharma Limited

第31章 その他の大手企業と革新的企業

  • Cipla Limited
  • Stada Arzneimittel AG
  • Lupin Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories
  • Mylan Inc.
  • Shanghai Generic Pharmaceuticals
  • Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd.
  • Sandoz
  • Glenmark
  • Kent Pharma
  • Zentiva
  • Apotex
  • Accord Healthcare Inc.
  • Acerus Pharmaceutical Drugs Corporation
  • AA Pharma Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

  • ジェネリック医薬品市場、2029年：新たな機会を提供する国
  • ジェネリック医薬品市場、2029年：新たな機会を提供するセグメント
  • ジェネリック医薬品市場、2029年：成長戦略
    • 市場動向による戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r25665

Generic pharmaceuticals are drugs designed to replicate an already marketed brand-name drug in terms of dosage form, safety, strength, mode of administration, quality, performance attributes, and intended use. The clinical benefits and action of a generic drug are identical to those of its brand-name counterpart.

The three primary types of generic pharmaceuticals are biosimilars and generics. Biosimilars are biological products closely resembling a reference biologic, demonstrating no clinically significant differences in safety, purity, or potency. These drugs are administered through various methods, including oral, injectable, dermal/topical, and inhalers, catering to therapies such as CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, biosimilars, and oncology. Distribution channels encompass hospital pharmacies, retail pharmacies, and online pharmacies.

The generic pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides generic pharmaceuticals market statistics, including generic pharmaceuticals industry global market size, regional shares, competitors with a generic pharmaceuticals market share, detailed generic pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the generic pharmaceuticals industry. The generic pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The generic pharmaceuticals market size has grown strongly in recent years. It will grow from $457.04 billion in 2024 to $492.16 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in healthcare awareness and expenditure, patent expiration of drugs, increased prevalence of respiratory diseases, changes in lifestyles, increased number of surgical procedures, strong economic growth in emerging markets, increase in insurance coverage, rapid growth in elderly population, increased number of approvals.

The generic pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $666.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing rising incidence of chronic diseases, rising regulators support, new methods for drug discovery, new methods for drug delivery and monitoring, rise in healthcare expenditure, increasing geriatric population, and major drug patents. Major trends in the forecast period include increasing use of 3D printing, adopting the use of artificial intelligence (ai), using biomarkers for drug development, collaborations for driving innovation, combination drug therapy, modification of existing epilepsy drugs, and rise of generic respiratory drugs.

The increasing prevalence of chronic diseases stands out as a significant driver for the generic pharmaceuticals market. As the number of individuals diagnosed with chronic conditions rises, there is a growing demand for medications. Branded drugs often come with a premium price tag, whereas generic drugs offer the same chemical composition at a lower cost. The affordability and comparable effectiveness of generic drugs make them a preferred choice for patients, particularly for prolonged treatments associated with chronic diseases. For instance, the World Health Organization (WHO) projects a 17% increase in deaths due to chronic diseases over the next decade.

The growth of the generic pharmaceutical market is expected to be fueled by the availability of cost-effective treatments from generic drugs. Cost-effective treatment refers to options that deliver significant health benefits at a reasonable cost. Generic drugs offer patients a more affordable treatment alternative, resulting in substantial savings for the healthcare system compared to branded medications. For example, in March 2024, data from the Assistant Secretary for Planning and Evaluation (ASPE), a principal advisory group in the U.S., indicated that in 2022, 43.3 million Medicare Part D enrollees-representing 82 percent of participants-filled 1.1 billion prescriptions for generic drugs. This translated to $5.7 billion in out-of-pocket expenses for patients and $32.9 billion in gross drug costs. Consequently, the cost-effectiveness of generic drugs is a significant driver of growth in the generic pharmaceutical market.

The advent of 3D printing technology holds the potential to revolutionize drug manufacturing within the generic pharmaceuticals market. The utilization of 3D printing in pharmaceuticals enhances research and development (R&D) efficiency, offering novel advantages for patients. Unlikeas traditional methods of generic drug manufacturing, 3D printing enables the production of drugs with customized sizes, shapes, and textures. This technology empowers manufacturers to create generic drugs with diverse release dates, appearances, and tastes. For example, GlaxoSmithKline (GSK) conducted a study incorporating ultraviolet (UV) and 3D printing to manufacture tablets for treating Parkinson's disease. Martin Wallace, the director of GSK Technology, expressed the company's commitment to investing in 3D printing for pill and tablet production. Additionally, Aprecia, a pharmaceutical company, introduced 'ZipDose' technology, specializing in the manufacture of 3D-printed drugs.

Leading companies in the generic pharmaceuticals market are actively introducing new products to maximize their market share and profits. The introduction of generic pharmaceutical products involves launching a generic version of a brand-name drug. For instance, in July 2023, Amneal Pharmaceuticals Inc., a publicly traded generics and specialty pharmaceutical company based in the United States, released its authorized generic for Xyrem 1 (Sodium Oxybate) oral solution CIII in the U.S. Sodium oxybate oral solution, 0.5 g/mL, is a central nervous system depressant prescribed for narcoleptic patients aged seven and older experiencing cataplexy or excessive daytime sleepiness (EDS).

In June 2022, Dr. Reddy's Laboratories, an India-based pharmaceutical company specializing in branded generics, acquired branded and generic injectable products from Eton Pharma for $50 million. This acquisition is intended to accelerate and broaden access to affordable medications for patients, including branded generics such as Biorphen (phenylephrine hydrochloride) injection and Rezipres, as well as to launch biosimilars. Eton Pharmaceuticals, Inc. is a U.S.-based pharmaceutical company that focuses on generic pharmaceuticals.

Major companies operating in the generic pharmaceuticals market include Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited, Cipla Limited, Stada Arzneimittel AG, Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Mylan Inc., Shanghai Generic Pharmaceuticals, Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd., Sandoz, Glenmark, Kent Pharma, Zentiva, Apotex, Accord Healthcare Inc., Acerus Pharmaceutical Drugs Corporation, AA Pharma Inc, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica, Boehringer Ingelheim, Mantecorp Farmasa, Libbs, Cimed, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Adcock Ingram, Eurolab, Ranbaxy (Pty) Ltd, Aspen

North America was the largest region in the generic pharmaceuticals market in 2024. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the generic pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The generic pharmaceuticals market consists of sales of paracetamol, cefixime, amoxicillin, and ofloxacin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generic Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generic pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generic pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generic pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Biosimilars, Generics
  • 2) By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled
  • 3) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others
  • 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies
  • Subsegments:
  • 1) By Biosimilars: Monoclonal Antibodies; Recombinant Proteins; Other Biologic Products
  • 2) By Generics: Branded Generics; Generic Small Molecules; Generic Extended-Release Formulations; Over-The-Counter (OTC) Generics
  • Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Novartis AG; Sun Pharmaceutical Industries Ltd.; Fresenius Kabi; Aurobindo Pharma Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generic Pharmaceuticals Market Characteristics

3. Generic Pharmaceuticals Market Trends And Strategies

4. Generic Pharmaceuticals Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Generic Pharmaceuticals Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Generic Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Generic Pharmaceuticals Market Growth Rate Analysis
  • 5.4. Global Generic Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Generic Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Generic Pharmaceuticals Total Addressable Market (TAM)

6. Generic Pharmaceuticals Market Segmentation

  • 6.1. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biosimilar
  • Generics
  • 6.2. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Inectables
  • Dermal/Topical
  • 6.3. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CNS
  • Cardiovascular
  • Dermatology
  • Genitourinary/Harmonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Inhaler
  • 6.4. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Generic Pharmaceuticals Market, Sub-Segmentation Of Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Other Biologic Products
  • 6.6. Global Generic Pharmaceuticals Market, Sub-Segmentation Of Generics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Branded Generics
  • Generic Small Molecules
  • Generic Extended-Release Formulations
  • Over-The-Counter (OTC) Generics

7. Generic Pharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generic Pharmaceuticals Market

  • 8.1. Asia-Pacific Generic Pharmaceuticals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generic Pharmaceuticals Market

  • 9.1. China Generic Pharmaceuticals Market Overview
  • 9.2. China Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generic Pharmaceuticals Market

  • 10.1. India Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generic Pharmaceuticals Market

  • 11.1. Japan Generic Pharmaceuticals Market Overview
  • 11.2. Japan Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generic Pharmaceuticals Market

  • 12.1. Australia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generic Pharmaceuticals Market

  • 13.1. Indonesia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generic Pharmaceuticals Market

  • 14.1. South Korea Generic Pharmaceuticals Market Overview
  • 14.2. South Korea Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generic Pharmaceuticals Market

  • 15.1. Western Europe Generic Pharmaceuticals Market Overview
  • 15.2. Western Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generic Pharmaceuticals Market

  • 16.1. UK Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generic Pharmaceuticals Market

  • 17.1. Germany Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generic Pharmaceuticals Market

  • 18.1. France Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generic Pharmaceuticals Market

  • 19.1. Italy Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generic Pharmaceuticals Market

  • 20.1. Spain Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generic Pharmaceuticals Market

  • 21.1. Eastern Europe Generic Pharmaceuticals Market Overview
  • 21.2. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generic Pharmaceuticals Market

  • 22.1. Russia Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generic Pharmaceuticals Market

  • 23.1. North America Generic Pharmaceuticals Market Overview
  • 23.2. North America Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generic Pharmaceuticals Market

  • 24.1. USA Generic Pharmaceuticals Market Overview
  • 24.2. USA Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generic Pharmaceuticals Market

  • 25.1. Canada Generic Pharmaceuticals Market Overview
  • 25.2. Canada Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generic Pharmaceuticals Market

  • 26.1. South America Generic Pharmaceuticals Market Overview
  • 26.2. South America Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generic Pharmaceuticals Market

  • 27.1. Brazil Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generic Pharmaceuticals Market

  • 28.1. Middle East Generic Pharmaceuticals Market Overview
  • 28.2. Middle East Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generic Pharmaceuticals Market

  • 29.1. Africa Generic Pharmaceuticals Market Overview
  • 29.2. Africa Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generic Pharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Generic Pharmaceuticals Market Competitive Landscape
  • 30.2. Generic Pharmaceuticals Market Company Profiles
    • 30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

31. Generic Pharmaceuticals Market Other Major And Innovative Companies

  • 31.1. Cipla Limited
  • 31.2. Stada Arzneimittel AG
  • 31.3. Lupin Pharmaceuticals, Inc.
  • 31.4. Dr. Reddy's Laboratories
  • 31.5. Mylan Inc.
  • 31.6. Shanghai Generic Pharmaceuticals
  • 31.7. Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd.
  • 31.8. Sandoz
  • 31.9. Glenmark
  • 31.10. Kent Pharma
  • 31.11. Zentiva
  • 31.12. Apotex
  • 31.13. Accord Healthcare Inc.
  • 31.14. Acerus Pharmaceutical Drugs Corporation
  • 31.15. AA Pharma Inc

32. Global Generic Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

34. Recent Developments In The Generic Pharmaceuticals Market

35. Generic Pharmaceuticals Market High Potential Countries, Segments and Strategies

  • 35.1 Generic Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Generic Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Generic Pharmaceuticals Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer